Literature DB >> 12441021

The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders.

Andrea J Rapkin1, Judith A Mikacich, Babak Moatakef-Imani, Natalie Rasgon.   

Abstract

Various mood and anxiety disorders are more prevalent in reproductive-aged women, and appear to be linked to hormonal and reproductive events. Premenstrual affective disorders consist of premenstrual syndrome, premenstrual dysphoric disorder, and premenstrual exacerbation of mood or anxiety disorders. Postpartum affective disorders can range from postpartum "blues" to postpartum depression with or without psychosis, and also include anxiety disorders, such as panic disorder, generalized anxiety disorder, social phobia, and obsessive-compulsive disorder. In perimenopausal women, the vulnerability to mood and anxiety disorders is increased. All of these disorders share risk factors, and have etiologic features in common, such as exposure to the rise and fall of ovarian sex steroids. The following is a review of these syndromes and their etiology, diagnosis, and treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441021     DOI: 10.1007/s11920-002-0069-7

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  73 in total

Review 1.  Depression and anxiety disorders.

Authors:  C S Brown
Journal:  Obstet Gynecol Clin North Am       Date:  2001-06       Impact factor: 2.844

2.  The perimenopause and affective disorders.

Authors:  P J Schmidt; C A Roca; M Bloch; D R Rubinow
Journal:  Semin Reprod Endocrinol       Date:  1997-02

3.  Serum allopregnanolone in women with postpartum "blues".

Authors:  R E Nappi; F Petraglia; S Luisi; F Polatti; C Farina; A R Genazzani
Journal:  Obstet Gynecol       Date:  2001-01       Impact factor: 7.661

4.  Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study.

Authors:  A Ahokas; J Kaukoranta; K Wahlbeck; M Aito
Journal:  J Clin Psychiatry       Date:  2001-05       Impact factor: 4.384

5.  Physiological aspects of steroids with anaesthetic properties.

Authors:  M Holzbauer
Journal:  Med Biol       Date:  1976-08

6.  The impact of partner support in the treatment of postpartum depression.

Authors:  S Misri; X Kostaras; D Fox; D Kostaras
Journal:  Can J Psychiatry       Date:  2000-08       Impact factor: 4.356

7.  Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects.

Authors:  I Sundström; A Andersson; S Nyberg; D Ashbrook; R H Purdy; T Bäckström
Journal:  Neuroendocrinology       Date:  1998-02       Impact factor: 4.914

8.  A menopause-specific quality of life questionnaire: development and psychometric properties.

Authors:  J R Hilditch; J Lewis; A Peter; B van Maris; A Ross; E Franssen; G H Guyatt; P G Norton; E Dunn
Journal:  Maturitas       Date:  1996-07       Impact factor: 4.342

9.  A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study.

Authors:  N E Avis; D Brambilla; S M McKinlay; K Vass
Journal:  Ann Epidemiol       Date:  1994-05       Impact factor: 3.797

10.  Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes.

Authors:  U Halbreich; N Rojansky; S Palter
Journal:  Fertil Steril       Date:  1991-12       Impact factor: 7.329

View more
  21 in total

1.  Progesterone reduces depressive behavior of young ovariectomized, aged progestin receptor knockout, and aged wild type mice in the tail suspension test.

Authors:  Cheryl A Frye
Journal:  J Psychopharmacol       Date:  2009-12-04       Impact factor: 4.153

2.  Progesterone attenuates depressive behavior of younger and older adult C57/BL6, wildtype, and progesterone receptor knockout mice.

Authors:  Cheryl A Frye
Journal:  Pharmacol Biochem Behav       Date:  2011-06-06       Impact factor: 3.533

3.  Sex- and Estrus-Dependent Differences in Rat Basolateral Amygdala.

Authors:  Shannon R Blume; Mari Freedberg; Jaime E Vantrease; Ronny Chan; Mallika Padival; Matthew J Record; M Regina DeJoseph; Janice H Urban; J Amiel Rosenkranz
Journal:  J Neurosci       Date:  2017-09-27       Impact factor: 6.167

4.  Transdermal Estradiol Treatment for Postpartum Depression: A Pilot, Randomized Trial.

Authors:  Katherine L Wisner; Dorothy K Y Sit; Eydie L Moses-Kolko; Kara E Driscoll; Beth A Prairie; Catherine S Stika; Heather F Eng; John L Dills; James F Luther; Stephen R Wisniewski
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

5.  The role of sleep difficulties in the vasomotor menopausal symptoms and depressed mood relationships: an international pooled analysis of eight studies in the InterLACE consortium.

Authors:  Hsin-Fang Chung; Nirmala Pandeya; Annette J Dobson; Diana Kuh; Eric J Brunner; Sybil L Crawford; Nancy E Avis; Ellen B Gold; Ellen S Mitchell; Nancy F Woods; Joyce T Bromberger; Rebecca C Thurston; Hadine Joffe; Toyoko Yoshizawa; Debra Anderson; Gita D Mishra
Journal:  Psychol Med       Date:  2018-02-12       Impact factor: 7.723

6.  Estradiol Modulates Neural and Behavioral Arousal in Women With Posttraumatic Stress Disorder During a Fear Learning and Extinction Task.

Authors:  Anneliis Sartin-Tarm; Marisa C Ross; Anthony A Privatsky; Josh M Cisler
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-04-30

7.  Estrogen levels are associated with extinction deficits in women with posttraumatic stress disorder.

Authors:  Ebony M Glover; Tanja Jovanovic; Kristina B Mercer; Kimberly Kerley; Bekh Bradley; Kerry J Ressler; Seth D Norrholm
Journal:  Biol Psychiatry       Date:  2012-04-12       Impact factor: 13.382

Review 8.  Neuroendocrine pathways underlying risk and resilience to PTSD in women.

Authors:  Meghna Ravi; Jennifer S Stevens; Vasiliki Michopoulos
Journal:  Front Neuroendocrinol       Date:  2019-09-19       Impact factor: 8.606

9.  Inhibition of fear is differentially associated with cycling estrogen levels in women.

Authors:  Ebony M Glover; Kristina B Mercer; Seth D Norrholm; Michael Davis; Erica Duncan; Bekh Bradley; Kerry J Ressler; Tanja Jovanovic
Journal:  J Psychiatry Neurosci       Date:  2013-09       Impact factor: 6.186

10.  Female fear: influence of estrus cycle on behavioral response and neuronal activation.

Authors:  Wei Chen; Jessica Shields; Wei Huang; Jean A King
Journal:  Behav Brain Res       Date:  2009-01-23       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.